The Second Trump White House Could Drastically Reshape Infectious Disease Research. Here’s What’s at Stake.

Donald Trump’s pick to lead the federal health agency has vowed to replace hundreds of staffers and shift research away from infectious diseases and vaccines. Such an overhaul could imperil the development of life-saving treatments, experts warn.